Core Viewpoint - A class action lawsuit has been filed against Plug Power Inc. and certain senior executives for securities fraud, following significant stock drops attributed to potential violations of federal securities laws [1][3]. Company Overview - Plug Power specializes in hydrogen fuel cell turnkey solutions for electric mobility and stationary power markets, and develops infrastructure such as hydrogen production plants [4]. Legal Proceedings - Investors have until April 3, 2026, to request to lead the case, which is pending in the U.S. District Court for the Northern District of New York, captioned Ortolani v. Plug Power Inc., et al. [3]. Financial Impact - Plug Power announced a $1.66 billion loan guarantee from the U.S. Department of Energy to finance the construction of hydrogen production projects, but allegedly overstated the likelihood of receiving these funds [4]. - The stock price dropped significantly following key announcements: - On October 7, 2025, the abrupt departure of CEO Andrew Marsh and President Sanjay Shrestha led to a 6.3% drop, from $4.13 to $3.87 per share [5]. - On November 10, 2025, the suspension of activities under the DOE loan program caused a 3.4% drop, from $2.65 to $2.56 per share [6]. - On November 14, 2025, confirmation of the suspension of plans to construct hydrogen facilities resulted in a 17.6% drop, from $2.49 to $2.25 per share [7].

Core Viewpoint - Rosen Law Firm has announced a class action lawsuit on behalf of purchasers of Picard Medical, Inc. securities during the specified Class Period, highlighting potential investor compensation opportunities [1][2]. Group 1: Class Action Details - The class action lawsuit pertains to securities purchased between September 2, 2025, and October 31, 2025 [1]. - Investors who purchased Picard Medical securities during this period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. Group 2: Allegations Against Picard Medical - The lawsuit alleges that defendants made materially false and misleading statements and failed to disclose adverse facts about Picard's business and operations [4]. - Specific allegations include involvement in a fraudulent stock promotion scheme, use of offshore accounts for share dumping, and omission of critical information regarding false rumors and artificial trading activity [4]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company and being ranked No. 1 for settlements in 2017 [3]. - The firm has recovered hundreds of millions of dollars for investors, securing over $438 million in 2019 alone [3].

Core Viewpoint - A class action securities lawsuit has been filed against Ultragenyx Pharmaceutical Inc. for alleged securities fraud affecting investors between August 3, 2023, and December 26, 2025 [1] Group 1 - The lawsuit is initiated by Kahn Swick & Foti, LLC and its partner, former Attorney General of Louisiana, Charles C. Foti, Jr. [1] - The action seeks to recover losses for investors adversely affected by the alleged fraud [1]

Core Viewpoint - Ademi LLP is investigating potential securities fraud claims against IonQ, Inc. due to possible inaccuracies in statements regarding its business operations and prospects [1] Group 1: Investigation Focus - The investigation is centered on whether IonQ's reported revenues were reliant on federal government "backdoor earmarks" [2] - There are concerns that IonQ may have inflated both the amount and nature of its revenue [2] - The investigation also examines the sale of nearly $400 million worth of IonQ stock by its executives [2]

Core Viewpoint - The lawsuit against BellRing Brands, Inc. alleges that the company misrepresented its sales growth as being driven by consumer demand, while in reality, it was primarily due to inventory stockpiling by key customers, leading to a significant decline in share price following the revelation of competitive pressures [4][5][6]. Group 1: Lawsuit Details - The lawsuit is filed on behalf of investors who purchased securities from November 19, 2024, to August 4, 2025, claiming that BellRing misled investors about its sales growth being attributed to "organic growth" and "strong macro tailwinds" [4]. - BellRing downplayed competitive pressures, asserting that it had a "competitive moat" in the ready-to-drink category, which was later contradicted by the actual sales performance [4]. - Following the destocking of inventory, BellRing acknowledged that competitive pressures were materially weakening demand, contradicting earlier claims [4]. Group 2: Financial Impact - On May 6, 2025, BellRing disclosed that key retailers had lowered their inventory levels, predicting a mid-single-digit headwind to third-quarter growth, resulting in a share price drop of approximately 19%, from $78.43 to $63.55 [5]. - On August 4, 2025, the company reported a disappointing sales outlook for fiscal year 2025, narrowing its net sales forecast to between $2.28 billion and $2.32 billion, which led to a further decline in share price by about 33%, from $53.64 to $36.18 [6].

Core Viewpoint - Vistagen Therapeutics, Inc. is facing a class action securities lawsuit due to alleged securities fraud related to its Phase 3 PALISADE-3 trial of fasedienol, which did not meet its primary endpoint, leading to a significant decline in stock price [1][2]. Group 1: Lawsuit Details - The lawsuit aims to recover losses for investors affected by alleged securities fraud between April 1, 2024, and December 16, 2025 [1]. - Defendants allegedly made positive statements while concealing adverse facts about the Phase 3 PALISADE-3 trial of fasedienol, which is intended for treating social anxiety disorder [2]. - Following the announcement that the trial did not show statistically significant improvement, Vistagen's stock price plummeted from $4.36 to $0.86, a decline of over 80% [2]. Group 2: Next Steps for Investors - Investors who suffered losses during the relevant timeframe have until March 16, 2026, to request appointment as lead plaintiff, although participation in any recovery does not require this [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees [3]. Group 3: Firm Background - Levi & Korsinsky has a strong track record, having secured hundreds of millions for shareholders and being recognized as a top securities litigation firm in the U.S. for seven consecutive years [4].

NEW YORK, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in CoreWeave, Inc. ("CoreWeave, Inc." or the "Company") (NASDAQ: CRWV) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of CoreWeave, Inc. investors who were adversely affected by alleged securities fraud between March 28, 2025 and December 15, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/coreweave-i ...

NEW YORK, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Klarna Group plc ("Klarna Group plc" or the "Company") (NYSE: KLAR) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Klarna Group plc investors who were adversely affected by alleged securities fraud. This lawsuit is on behalf of persons who purchased or otherwise acquired Klarna securities pursuant and/or traceable to the registration statement and related prospect ...

NEW YORK, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Ardent Health, Inc. ("Ardent Health, Inc." or the "Company") (NYSE: ARDT) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Ardent Health, Inc. investors who were adversely affected by alleged securities fraud between July 18, 2024 and November 12, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/ar ...

NEW YORK, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Integer Holdings Corporation ("Integer Holdings Corporation" or the "Company") (NYSE: ITGR) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Integer Holdings Corporation investors who were adversely affected by alleged securities fraud between July 25, 2024 and October 22, 2025. Follow the link below to get more information and be contacted by a member of our team: ...